Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novartis has reported sales of $11.7bn for the second quarter ended in June 30, 2010, an increase of 11%, compared to $10.7bn for the comparable period in 2009.
Subscribe to our email newsletter
Novartis’ operating income rose 25% to $3bn, compared to $2.4bn for the comparable period in 2009.
Earnings per share (EPS) increased 18% to $1.06 while core EPS was up 14% in the second quarter to $1.20.
In the first half ended, Novartis Group’s net sales rose by 18% to $23.8bn, whereas there was a 37% increase in the operating income.
Earnings per share (EPS) in the first half of 2010 increased by 33% to $2.34, while core EPS was up 29% to $2.65 in the first half of 2010.
Joseph Jimenez, CEO of Novartis, said: “I am pleased that Novartis once again delivered strong above-market, double-digit growth in the second quarter of 2010. Our results were driven by our success in innovation across the portfolio, as recently launched products comprised 21% of Group sales. We are making great progress on all three strategic priorities of innovation, growth and productivity.”